Group 1: Investor Relations Activity - The investor relations activity included a site visit to Suning Max Nanjing Huaihai Road store [1] - Participants included representatives from Debang Fund and Western Securities [1] - The meeting took place on October 14, 2025, at 15:00 [1] Group 2: Store Overview and Insights - Investors observed the store's basic conditions, customer flow, and user demographics [1] - Marketing strategies and sales performance of various brands were discussed [1] - User perceptions of brands and services such as Suning Bangke and Suning Friend were shared [1] Group 3: Compliance and Information Disclosure - The company adhered to the "Information Disclosure Management System" to ensure accurate and timely information disclosure [1] - No significant undisclosed information leaks occurred during the meeting [1] - A commitment letter was signed in accordance with the Shenzhen Stock Exchange requirements [1]

Group 1: Event Details - The investor relations activity took place on October 13, 2025, at 15:30 [1] - The location of the event was Suning Max Nanjing Huaihai Road Store [1] - Participants included representatives from various investment firms such as Huaxia Fund and Northeast Securities [1] Group 2: Store Overview - Investors visited the Suning Max Nanjing Huaihai Road Store to understand the store's basic situation, brand partnerships, and category structure [1] - The discussion included topics on membership operations, store sales activities, and services provided by Suning Friend [1] Group 3: Compliance and Disclosure - The company adhered to the "Information Disclosure Management System" to ensure the accuracy and completeness of information disclosed [1] - There were no instances of undisclosed significant information leaks during the event [1] - The company signed a research "Commitment Letter" as required by the Shenzhen Stock Exchange [1]

Group 1: Company Strategy and Product Development - The company aims to develop its own lithium battery packs to enhance production and sales efficiency, partnering with ALDI in Europe for electric tool solutions [1] - The acquisition of BATAVIA B.V. in October 2023 is intended to leverage its design and sales resources, creating synergies in R&D, manufacturing, and marketing [1] Group 2: Product Revenue Breakdown - In 2024, the revenue breakdown for major product categories is as follows: - Electric heating products: approximately 25% - Spraying products: approximately 28% - Blowing and suction products: approximately 14% - Other products make up the remaining share [1] Group 3: Product Range Expansion - The company is actively extending its product range from general (DIY) to professional and industrial levels, aiming to serve a broader market [2] - Current products like heat guns have already bridged the gap between general and professional levels, with other categories like nail guns and spraying products also introducing industrial-grade options [2] Group 4: Employee Incentives - The company completed a share buyback in August 2024, utilizing approximately 50 million yuan to repurchase over 2 million shares, which will be used for employee stock ownership or incentive plans [2]

Group 1: Company Overview and Strategy - The company has clarified its strategic goal of "AI + IoT," focusing on an AIoT platform and modular application solutions for smart spaces [1] - The AIoT intelligent IoT control platform V7 was launched, optimizing applications such as cold load forecasting and energy consumption anomaly detection [1] - The company has established an "AI + IoT" open laboratory, collaborating with 9 universities and entrepreneurial teams to co-create AI applications [1] Group 2: Financial Performance - In the first half of 2025, the company achieved a revenue of 990 million yuan, with a net loss of 88.76 million yuan due to fluctuations in downstream demand and project delays [1] - Operating cash flow has improved compared to the previous period, with a 3.2% decrease in sales, management, and financial expenses year-on-year [2] - The signed amount for AIoT platform products increased from 7.97 million yuan to 25.04 million yuan, a year-on-year growth of 214.35% [2] - Revenue from AIoT platform products rose from 10.87 million yuan to 13.56 million yuan, reflecting a year-on-year increase of 24.77% [2] Group 3: Market Position and Future Outlook - By the end of 2024, the company had served 57 out of 93 large manufacturing listed companies in Shenzhen, achieving a coverage rate of 61.3% [2] - The company aims to replicate successful smart space cases in more leading enterprises in finance, technology, and high-end manufacturing by 2030 [2] - The company has served over 3,000 enterprise park projects, focusing on intelligent and energy-saving construction [4]

Group 1: Company Overview - The company specializes in the research, design, system integration, and investment operation of photovoltaic power stations, while also engaging in new energy technologies and products such as energy storage and smart microgrids [3] - Founded in 2009, the company has a strong foundation with founders from prestigious universities and extensive experience in the energy sector [3] - The company has successfully transitioned to focus on photovoltaic new energy development and has contributed to the rise of mountain photovoltaic projects in Southwest China [3][4] Group 2: Business Strategy and Innovations - The company is undergoing a comprehensive strategic transformation, integrating energy with AI, robotics, computing power, and new materials [4] - Collaborations with Ant Group aim to leverage AI in design and operational management, enhancing efficiency in energy services [4] - Development of third-generation AI smart battery swap robots and partnerships with leading universities and manufacturers to enhance operational capabilities [4] Group 3: Market Expansion and Performance - The company is targeting overseas markets for its energy storage business, with a focus on Europe and the Middle East, having established a subsidiary in Amsterdam [5] - The company aims to provide integrated "photovoltaic + energy storage" solutions, enhancing its competitive edge in international markets [5] - The main revenue source remains photovoltaic system integration, with confidence in profit targets for the upcoming year due to favorable national policies [7]

Group 1: Business Overview - The company is actively expanding its liquid cooling solutions in response to market demand, targeting high-power products for clients [2] - Liquid cooling components are a future development direction for the company, with ongoing advancements in self-developed liquid cooling modules [2] - The company collaborates with the industry chain and universities for material research and development to enhance product delivery [2] Group 2: Market Position and Client Engagement - The company leverages its strong client relationships in the testing field to identify and address customer needs effectively [3] - The server testing sector contributes approximately 25% to the company's overall revenue [3] Group 3: Order Forecast and Business Segments - Orders for AI server testing equipment are expected to be optimistic due to demand from key clients [3] - The automotive electronics segment is experiencing rapid order growth, with existing orders already in the delivery phase [3] - The MLCC industry has seen a resurgence since last year, leading to a significant increase in equipment orders [3] - The semiconductor sector is also witnessing growth in revenue, although its overall contribution remains small [3]

Group 1: Purpose of Overseas Listing - The overseas listing aims to strengthen international influence and align with the company's global development strategy, as it ranks among the top 30 global medical device companies with nearly half of its revenue from international business [2][3] - The listing will enhance the company's ability to connect with overseas market resources, providing strong capital support for competition with international giants [3][4] - It will facilitate the design and implementation of global employee incentive plans, attracting top talent for sustainable development [3][4] Group 2: Timing and Market Conditions - The current period is deemed the best strategic window for overseas listing due to significant changes in the global medical industry, driven by factors like aging populations and technological advancements [4][5] - The stable capital market environment in Hong Kong is favorable for high-quality assets, making it an opportune time for international capital operations [5][6] Group 3: Financial Projections and Growth - The company expects a positive year-on-year growth in overall revenue by Q3 2025, with international business growth accelerating due to ongoing localization efforts [5][6] - Domestic market recovery is anticipated, although the revenue recognition cycle has lengthened, indicating a gradual improvement starting in Q3 [5][6] Group 4: Use of Funds from IPO - The funds raised from the IPO will be allocated to advancing international strategies, enhancing R&D investments, and supporting operational needs [8][9] - The company emphasizes a focus on self-research and development, with acquisitions serving as a supplementary strategy to enhance core competitiveness [9][10] Group 5: Shareholder Value and Communication - The company is committed to protecting minority shareholders' interests through performance growth, stable dividends, and transparent information disclosure [11][12] - A profit distribution policy has been established, ensuring at least 65% of distributable profits are allocated to dividends, with a total dividend payout of 35.7 billion CNY since its IPO [12][13] Group 6: Innovations in Medical Technology - The launch of new AI models and high-speed biochemical analysis systems aims to enhance clinical decision-making and improve operational efficiency [13][14][15] - The new systems are designed to address common challenges in testing, significantly improving speed and accuracy, thereby supporting market share growth [15][16]

Group 1: Company Strategy and Focus - The company is fully transforming to focus on innovative drug research and development, with a core emphasis on chemical and traditional Chinese medicine innovations [2][3] - Key therapeutic areas include pain management, with a focus on peptide and small molecule drugs, and oncology, specifically PDC drug development [2] - The company employs a dual approach of independent research and project acquisition to enhance its innovation capabilities and accelerate the commercialization of results [3] Group 2: Product Development and Market Outlook - The company has submitted production applications for its traditional Chinese medicine product, Jiao Qi Pain Relief Gel, which is currently under review [2] - The JIJ02 gel is expected to complete Phase I clinical trials in the first half of next year and will initiate Phase II trials thereafter [5] - The company is optimistic about the market potential for its anti-inflammatory pain relief patch, particularly due to the increasing prevalence of chronic pain among the aging population [4] Group 3: Market Strategy and Sales Channels - The sales strategy for the anti-inflammatory pain relief patch primarily targets OTC channels, with plans to enhance sales through resource sharing and product diversification [4] - The company is currently in the bidding phase for the 11th batch of national drug procurement, with submission of application materials and public pricing scheduled for October 27 [6] - The company plans to leverage e-commerce platforms like Xiaohongshu, Douyin, and Kuaishou to reach health-conscious consumers through content marketing and KOL collaborations [9]

Group 1: Impact of External Factors - The company's overseas sales are primarily focused on Asia, Europe, and America, with revenue from the U.S. market being relatively low, indicating limited impact from potential U.S. tariffs [2] - The company will monitor international developments and adapt cross-border service plans based on customer needs, while seeking opportunities in other overseas markets [2] Group 2: Product Lifecycle and Innovation - The company's anime card products leverage well-known IPs and national cultural elements, regularly updating game content to enhance player experience and extend product lifecycle [3] - The company actively engages players through events and competitions, fostering loyalty and community [3] Group 3: Player Engagement and Market Strategy - The core player base for the Pokémon "Shining Star" product remains stable, with successful engagement strategies during product transitions [4] - The company plans to increase the availability of "Shining Star" based on market demand and explore diverse distribution channels [5] Group 4: New Product Launches - The company introduced the "Three Kingdoms Fantasy Battle" TCG card game at the Guangzhou Animation and Game Festival, marking a significant innovation in combining gaming devices with TCG cards [6] - This new model allows for seamless integration of online and offline experiences, creating a novel sales approach for card products in amusement parks [7]

Group 1: Business Expansion Plans - The company focuses on water and environmental protection, emphasizing "internal growth and external expansion" while integrating supply, drainage, and treatment [2] - Plans to strengthen cooperation within Sichuan province and explore markets outside the province to leverage scale effects and create incremental performance [2] - Actively pursuing diversification in the water and environmental sector, including recycled water utilization and entering niche markets such as kitchen waste disposal and resource recovery from waste [2][3] Group 2: Project Timelines - The Chengdu Water Supply Plant Phase III, with a capacity of 400,000 tons/day, is expected to be operational within 2025 [3] - Several wastewater treatment projects are anticipated to be operational within the next 1-2 years, including the Chengdu Sixth Reclaimed Water Plant Phase II and the Chengdu Cooperation Wastewater Treatment Plant Phase IV [3] - The Chengdu Wanxing Environmental Power Plant Phase III is projected to be operational in 2026 [3] Group 3: Dividend Considerations - The company has significant capital expenditures due to multiple ongoing projects, which are expected to stabilize in the next 1-2 years as projects come online [3] - Plans to enhance dividend levels based on comprehensive assessments of operational funding needs, profitability, and cash flow [3] Group 4: Revenue Composition - "Other industries" in the 2025 semi-annual report includes revenue from services outside of water supply and wastewater treatment, such as detection, design, and equipment sales [3]